Pharmaceutical Rapamycin Sirolimus Rapamycin

Product Details
Customization: Available
CAS No.: 53123-88-9
Formula: C51h79no13
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2025

Suppliers with verified business licenses

Registered Capital
1000000 RMB
Plant Area
101~500 square meters
  • Pharmaceutical Rapamycin Sirolimus Rapamycin
  • Pharmaceutical Rapamycin Sirolimus Rapamycin
  • Pharmaceutical Rapamycin Sirolimus Rapamycin
  • Pharmaceutical Rapamycin Sirolimus Rapamycin
  • Pharmaceutical Rapamycin Sirolimus Rapamycin
  • Pharmaceutical Rapamycin Sirolimus Rapamycin
Find Similar Products
  • Overview
  • Product Description
  • Product Details
  • Application&Function
  • Specification
Overview

Basic Info.

Model NO.
QS-Rapamycin
EINECS
610-965-5
Packaging Material
Negotiable
Storage Method
Normal
Shelf Life
>12 Months
Nutrient Composition
Rapamycin
Resource
Rapamycin
The content of active substances
>99%
Product Name
Rapamycin
Name
Rapamycin Powder
Appearance
White Powder
Colour
White
Grade
Pharmaceutical Grade
Assay
>99%
Application
Pharmaceutica
Specific
COA
Test Method
HPLC
Mf
C51h79no13
Mv
914.17186
Melting Point
185c
Density
1.182
Boiling Point
973.017c
Water-Soluble
2.4
Transport Package
Negotiable
Specification
>99%
Trademark
QS-Rapamycin
Origin
Xi`an
Production Capacity
50kg/Month

Product Description

Pharmaceutical Rapamycin Sirolimus Rapamycin
Pharmaceutical Rapamycin Sirolimus Rapamycin
Product Description
Pharmaceutical Rapamycin Sirolimus RapamycinPharmaceutical Rapamycin Sirolimus Rapamycin
Product Details
Pharmaceutical Rapamycin Sirolimus Rapamycin
Name Rapamycin Powder
Product Name Rapamycin
Appearance White Powder
Assay >99%
Application Pharmaceutica
Melting Point 185C
MF C51H79NO13
MV 914.17186
Rapamycin a triene macrolide antibiotic, exhibits antifungal, anti-inflammatory, antitumor, and immunosuppressive properties. It inhibits T-cell activation and proliferation, suppresses p70 S6 kinase activation, and strongly binds to FK-506 binding proteins. Additionally, rapamycin targets the mammalian target of rapamycin, a protein involved in signaling pathways that promote tumor growth. By binding to the receptor protein FKBP12, the rapamycin FKBP12 complex interacts with mTOR, preventing its engagement with downstream target proteins and thereby inhibiting tumor progression.
Application&Function
Pharmaceutical Rapamycin Sirolimus RapamycinRapamycin, a triene macrolide antibiotic, possesses antifungal, anti-inflammatory, antitumor, and immunosuppressive effects. It effectively blocks T-cell activation and proliferation, inhibits the activation of p70 S6 kinase, and forms strong interactions with FK506 binding proteins. Additionally, rapamycin targets and suppresses the activity of mTOR (mammalian target of rapamycin), a protein that plays a key role in signaling pathways driving tumor growth. By binding to the receptor protein FKBP12, the resulting rapamycin/FKBP12 complex attaches to mTOR, disrupting its ability to interact with downstream target proteins and thereby inhibiting tumor-promoting signaling.
Pharmaceutical Rapamycin Sirolimus Rapamycin
Specification

Pharmaceutical Rapamycin Sirolimus Rapamycin

Pharmaceutical Rapamycin Sirolimus RapamycinPharmaceutical Rapamycin Sirolimus RapamycinPharmaceutical Rapamycin Sirolimus RapamycinPharmaceutical Rapamycin Sirolimus RapamycinPharmaceutical Rapamycin Sirolimus RapamycinPharmaceutical Rapamycin Sirolimus RapamycinPharmaceutical Rapamycin Sirolimus RapamycinPharmaceutical Rapamycin Sirolimus RapamycinPharmaceutical Rapamycin Sirolimus Rapamycin

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier